Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -240 | 20 | 110 | 120 | 70 |
| Depreciation Amortization | 50 | 0 | 0 | 0 | 0 |
| Other Working Capital | 400 | -10 | 10 | -1 | -20 |
| Other Operating Activity | 110 | -80 | -360 | -249 | -160 |
| Operating Cash Flow | $320 | $-70 | $-240 | $-130 | $-110 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | 0 | 0 | 0 | 0 |
| Other Investing Activity | -3,540 | 7 | 30 | 20 | 10 |
| Investing Cash Flow | $-3,550 | $7 | $30 | $20 | $10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,980 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $5,980 | $0 | $0 | $0 | $0 |
| Beginning Cash Position | 80 | 540 | 760 | 760 | 760 |
| End Cash Position | 2,840 | 470 | 540 | 650 | 660 |
| Net Cash Flow | $2,760 | $-70 | $-210 | $-100 | $-100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 320 | -70 | -240 | -130 | -110 |
| Free Cash Flow | 320 | -70 | -240 | -130 | -110 |